Literature DB >> 9695122

N-methyl-D-aspartate antagonists, glutamate release inhibitors, 4-aminopyridine at neuromuscular transmission.

H Koyuncuoğlu1, I Kara, M A Günel, A Nurten, P Yamantürk.   

Abstract

It is thought that glutamate (GLU) and acetylcholine (ACh) are co-released in the neuromuscular junction (NMJ). Consequently, GLU is also a mediator or modulator of neuromuscular transmission (n-m) together with ACh. Therefore we decided to investigate the role of GLU in n-m by using isolated rat phrenic nerve-hemidiaphragm preparations. Since the GLU receptors present at NMJ have been reported to be predominantly N-methyl-D-aspartate (NMDA) subtype, some non-competitive and competitive NMDA receptor blockers, MK801, ketamine, dextromethorphan and CGP 37849, and GLU release inhibitors, clonidine, guanfacine, tizanidine were used at their optimum concentrations in medium after having found them from dose-response curves. The preparations were first stimulated indirectly in the presence of the optimum concentrations of the drugs used and tensions developed were recorded isometrically through a force displacement transducer on a polygraph linked to a computer + Math coprocessor by an analog converter. All drugs at their optimum concentrations suppressed contractions significantly. Prolyl-glycinamide (PLG) or phenyl-succinate, both of which are the inhibitors of GLU production also suppressed the contraction significantly, following depletion of GLU stores by tetanic contraction in nerve endings. 4-Aminopyridine, which has been shown to release GLU augmented the contractions which were also completely abolished by the NMDA receptor antagonists or GLU release inhibitors at their higher concentrations than their optimum ones. The direct stimulation of the muscles elicited statistically insignificant but higher contractions than controls at the optimum concentrations of the antagonists or inhibitors in medium. The results were discussed and it was concluded that blockade of NMDA receptors, the inhibition of GLU released or the suppression of GLU production inhibit the contractions of the rat-isolated hemidiaphragms elicited by indirect electrical stimulation, without altering acetylcholinergic part of the contraction cascade.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695122     DOI: 10.1006/phrs.1998.0318

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  Formation and maintenance of ventilatory long-term facilitation require NMDA but not non-NMDA receptors in awake rats.

Authors:  Michelle McGuire; Chun Liu; Ying Cao; Liming Ling
Journal:  J Appl Physiol (1985)       Date:  2008-06-26

2.  Glutamate receptors localize postsynaptically at neuromuscular junctions in mice.

Authors:  Tessily A Mays; Jamie L Sanford; Toshihiko Hanada; Athar H Chishti; Jill A Rafael-Fortney
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

3.  Regulation of cholinergic phenotype in developing neurons.

Authors:  Xinhuai Liu; Ion R Popescu; Janna V Denisova; Rachael L Neve; Roderick A Corriveau; Andrei B Belousov
Journal:  J Neurophysiol       Date:  2008-03-05       Impact factor: 2.714

4.  Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.

Authors:  Jinhua Wu; Hong Zou; Judith A Strong; Jun Yu; Xuedong Zhou; Qinglian Xie; Guoping Zhao; Meilei Jin; Lei Yu
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

5.  Blockage of neuromuscular glutamate receptors impairs reinnervation following nerve crush in adult mice.

Authors:  Kirkwood E Personius; Danielle Siebert; Dennis W Koch; Susan B Udin
Journal:  Front Cell Neurosci       Date:  2022-09-22       Impact factor: 6.147

6.  Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia.

Authors:  Ellya Bukharaeva; Anastasia Shakirzyanova; Venera Khuzakhmetova; Guzel Sitdikova; Rashid Giniatullin
Journal:  Front Cell Neurosci       Date:  2015-10-06       Impact factor: 5.505

7.  Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration.

Authors:  Darine Froy N Mabunga; Donghyun Park; Onjeon Ryu; Schley T Valencia; Keremkleroo Jym L Adil; Seonmin Kim; Kyoung Ja Kwon; Chan Young Shin; Se Jin Jeon
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.